Session date: 
06/21/2024 - 12:15pm to 1:00pm

Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

Neuroimmunology
Eoin, Flanagan, M.B., B.Ch. 
"MOG Antibody-Associated Disease; A focus on fulminant attacks and epidemiology"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

  • Recognize the potential for life-threatening attacks in MOGAD
  • Review the contribution of increased intracranial pressure to severe attacks in MOGAD
  • Summarize the evolving epidemiology of MOGAD

Dr. Flanagan has the following relevant financial relationships to disclose: Grant/Research support: UCB (R01NS113828); Other: Participated in Advisory Boards with Alexion, Genentech, Horizon Therapeutics and UCB and does intend to discuss the following off-label/investigative use of Pharmaceuticals UCB: Rozanolixizumab; Roche:  Satralizumab

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Support location: 
Minnesota

Please login or register to take this course.
Support location: 
Minnesota